Pathogenic tau modifications occur in axons before the somatodendritic compartment in mossy fiber and Schaffer collateral pathways

Acta Neuropathologica Communications
Kyle R ChristensenNicholas M Kanaan

Abstract

The deposition of tau pathology in Alzheimer's disease (AD) may occur first in axons of neurons and then progress back into the cell bodies to form neurofibrillary tangles, however, studies have not directly analyzed this relationship in relatively discrete circuits within the human hippocampus. In the early phases of tau deposition, both AT8 phosphorylation and exposure of the amino terminus of tau occurs in tauopathies, and these modifications are linked to mechanisms of synaptic and axonal dysfunction. Here, we examined the localization of these tau pathologies in well-characterized post-mortem human tissue samples from the hippocampus of 44 cases ranging between non-demented and mild cognitively impaired to capture a time at which intrahippocampal pathways show a range in the extent of tau deposition. The tissue sections were analyzed for AT8 (AT8 antibody), amino terminus exposure (TNT2 antibody), and amyloid-β (MOAB2 antibody) pathology in hippocampal strata containing the axons and neuronal cell bodies of the CA3-Schaffer collateral and dentate granule-mossy fiber pathways. We show that tau pathology first appears in the axonal compartment of affected neurons in the absence of observable tau pathology in the correspondin...Continue Reading

References

Oct 1, 1992·Molecular Biology of the Cell·D N DrechselM W Kirschner
Apr 10, 1992·Science·J A Hardy, G A Higgins
Aug 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·N W KowallB A Yankner
Jan 1, 1991·Acta Neuropathologica·H Braak, E Braak
Jan 1, 1991·Acta Neuropathologica·E MasliahR D Terry
Jun 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·K S KosikD J Selkoe
Jan 1, 1986·Annals of the New York Academy of Sciences·L I BinderL I Rebhun
Jun 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·C L MastersK Beyreuther
May 16, 1984·Biochemical and Biophysical Research Communications·G G Glenner, C W Wong
May 1, 1995·Neurobiology of Aging·J W Mandell, G A Banker
May 1, 1995·Neurobiology of Aging·H Braak, E Braak
Mar 21, 2002·Journal of Microscopy·K A Dorph-PetersenH J Gundersen
Jun 19, 2002·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·Riitta A MiettinenEsa H Koivisto
Jul 16, 2003·Journal of Neurochemistry·Cathy AndorferPeter Davies
Jul 31, 2003·Proceedings of the National Academy of Sciences of the United States of America·T Chris GamblinVincent L Cryns
Sep 1, 1952·Brain : a Journal of Neurology·W R ADEY, M MEYER
Dec 24, 2004·Biochimica Et Biophysica Acta·Lester I BinderRobert W Berry
Mar 8, 2005·Neurobiology of Aging·Angela L Guillozet-BongaartsLester I Binder
Oct 15, 2005·Nature Reviews. Neuroscience·Michael Coleman
Nov 18, 2005·Neurobiology of Aging·Stephen W ScheffElliott J Mufson
Jan 13, 2006·Archives of Neurology·William R MarkesberyDavid R Wekstein
Aug 5, 2006·European Journal of Pharmacology·Karen F S Bell, A Claudio Cuello
Mar 14, 2008·International Journal of Experimental Pathology·Siddhartha Mondragón-RodríguezFrancisco García-Sierra
May 2, 2008·Progress in Neurobiology·Jian-Zhi Wang, Fei Liu
Sep 18, 2008·Journal of Neuroscience Research·Nichole E LaPointeScott T Brady
Mar 27, 2009·Brain : a Journal of Neurology·G LaceUNKNOWN MRC-CFAS
Oct 16, 2009·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Gerardo A MorfiniScott T Brady
Jan 12, 2010·Journal of Alzheimer's Disease : JAD·M Paul Murphy, Harry LeVine

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Methods Mentioned

BETA
FRET

Software Mentioned

Elements
Adobe Photoshop
NIS
Nikon NIS - Elements
Adobe Illustrator

Related Concepts

Related Feeds

Alzheimer's Disease: Tau & TDP-43

Alzheimer's disease is a neurodegenerative disease. This feed focuses on the underlying role of tau proteins and TAR DNA-binding protein 43, as well as other genetic factors, in Alzheimer's disease.